Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia

Medical Hypotheses

Volumn 66, Issue 3, 2006, Pages 509-512

  Shackelford, Rodney E ^a   Bhalodia, Ami R ^a   Cotelingam, James D ^a   Veillon, Diana M ^a   Lowery Nordberg, Mary ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM; IRON; TRANSFERRIN RECEPTOR;

ARTICLE; ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA MUTATED GENE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CELL GROWTH; CHROMOSOME 11Q; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; DISEASE SEVERITY; DNA SYNTHESIS; DRUG ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE;

B-LYMPHOCYTES; CELL CYCLE PROTEINS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; DISEASE PROGRESSION; DNA-BINDING PROTEINS; GENE DELETION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTES; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFERRIN; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 30344487243     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.08.056     Document Type: Article

References (29)

1. N. Chiorazzi, K.R. Rai, and M. Ferrarini Chronic lymphocytic leukemia New Engl J Med 352 2005 804 815
2. J.D. Hoyer, C.W. Ross, C.Y. Li, T.E. Witzig, R.D. Gascoyne, and G.W. Dewald True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases Blood 86 1995 1163 1169
3. H. Dohner, S. Stilgenbauer, K. Dohner, M. Bentz, and P. Lichter Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis J Mol Med 77 1999 266 281
4. S. Stilgenbauer, L. Bullinger, P. Lichter, H. Dohner German CLL Study Group (GCLLSG) Chronic lymphocytic leukemia.Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course Leukemia 16 2002 993 1007
5. J.D. Dickinson, L.M. Smith, W.G. Sanger, G. Zhou, P. Townley, and J.C. Lynch Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia Br J Haematol 128 2005 460 471
6. Y. Zhu, O. Monni, K. Franssila, E. Elonen, J. Vilpo, and H. Joensuu Deletions at 11q23 in different lymphoma subtypes Haematologica 85 2000 908 912
7. A. Cuneo, R. Bigoni, G.M. Rigolin, M.G. Roberti, R. Milani, and A. Bardi Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features J Clin Oncol 18 2000 2607 2614
8. E.J. Dann, and J.M. Rowe Biology and therapy of secondary leukemias Best Pract Res Clin Haematol l14 2001 119 137
9. E.U. Kurz, and S.P. Lees-Miller DNA damage-induced activation of ATM and ATM-dependent signaling pathways DNA Repair 3 2004 889 900
10. S.E. Artandi, and L.D. Attardi Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer Biochem Biophys Res Commun 331 2005 881 890
11. S.M. Gollin Chromosomal instability Curr Opin Oncol 16 2004 25 31
12. H.H. Chun, and R.A. Gatti Ataxia-telangiectasia, an evolving phenotype DNA Repair 3 2004 1187 1196
13. C. Schaffner, S. Stilgenbauer, G.A. Rappold, H. Dohner, and P. Lichter Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia Blood 94 1999 748 753
14. P. Starostik, T. Manshouri, S. O'Brien, E. Freireich, H. Kantarjian, and M. Haidar Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia Cancer Res 58 1998 4552 4557
15. V. Eclache, S. Caulet-Maugendre, H.A. Poirel, M. Djemai, J. Robert, and F. Lejeune Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders Cancer Genet Cytogen 152 2004 72 76
16. T. Stankovic, G.S. Stewart, C. Fegan, P. Biggs, J. Last, and P.J. Byrd Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage Blood 99 2002 300 309
17. S. Faderl, M.J. Keating, K.A. Do, S.Y. Liang, H.M. Kantarjian, and S. O'Brien Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL) Leukemia 16 2002 1045 1052
18. A. Cuneo, R. Bigoni, G.M. Rigolin, M.G. Roberti, A. Bardi, and F. Cavazzini Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance Haematologica 87 2002 44 51
19. Shackelford RE, Fu Y, Brooks TC, Manuszak RP, Sequeira AP, Wang S, et al. Iron chelators reduce spontaneous double-stranded DNA breaks in ataxia-telangiectasia cells. DNA Repair, in press.
20. P.A. Seligman, J. Kovar, and E.W. Gelfand Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways Pathobiology 60 1992 19 26
21. K. Thorstensen, and I. Romslo The transferrin receptor: its diagnostic value and its potential as therapeutic target Scand J Clin Lab Invest Suppl 215 1993 113 120
22. L.M. Neckers Regulation of transferrin receptor expression and control of cell growth Pathobiology 59 1991 11 18
23. Smilevska T, Stamatopoulos K, Samara M, Belessi C, Tsompanakou A, Paterakis G, et al. Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia. Leuk Res [Epub ahead of print].
24. Y. Beguin, S. Lampertz, D. De Groote, D. Igot, M. Malaise, and G. Fillet Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia Leukemia 7 1993 2019 2025
25. S. Taketani Aquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation Tohoku J Exp Med 205 2005 297 318
26. C.R. Chitambar Apoptotic mechanisms of gallium nitrate: basic and clinical investigations Oncology 13 Suppl. 10 2004 39 44
27. C.R. Chitambar Gallium nitrate for the treatment of non-Hodgkin's lymphoma Expert Opin Inv Drug 13 2004 531 541
28. J.N. Sarkaria, and J.S. Eshleman ATM as a target for novel radiosensitizers Semin Radiat Oncol 11 2001 316 327
29. F. Bertoni, E. Zucca, and F. Cavalli Mantle cell lymphoma Curr Opin Hematol 11 2004 411 418